OTC · Financial Statements

Evolutionary Genomics, Inc. (FNAM) Financial Statements

$0.00 OTC: FNAM Market Cap $1331

Evolutionary Genomics, Inc. most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-3.0M$-3.0M$-2.0M
Net Profit$-1.0M$-1.0M$-2.0M$-3.0M$-2.0M
EPS$-0.19$-0.13$-0.34$-0.52$-0.35
Op Margin-728.8%-631.5%-23038.4%——

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$4.0M$4.0M$4.0M$3.0M$2.0M
Total Liabilities$4.0M$5.0M$6.0M$7.0M$4.0M
Cash$0$0$0$0$1.0M
Borrowings$0$0$2.0M$4.0M$4.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-1.0M$-1.0M$-2.0M$-2.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-1.0M$0$0$0$0
Free Cash Flow$-1.0M$-1.0M$-2.0M$-2.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.47
FCF Yield-75131.48%
Quick Ratio3.92
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
FNAM Overview FNAM Dividend Run Stock Screener